Upgrade Alert for Mindray Medical International (MR)
Mindray Medical International (NYSE:MR) was upgraded from Underperform to Market Perform at JMP Securities today. The stock closed yesterday at $30.47 on volume of 6.5 million shares, above average daily volume of 549,000.
Based on a current price of $30.47, Mindray Medical International is currently 5.7% above its average consensus analyst price target of $28.74. Mindray Medical International shares have support at the 50-day moving average (MA) of $29.05 and additional support at the 200-day MA of $29.03.
In the past 52 weeks, Mindray Medical International share prices have been bracketed by a low of $25.90 and a high of $33.83 and closed yesterday at $30.47, 18% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.2% while the 50-day MA has advanced 0.3%.
Mindray Medical International Limited develops, manufactures, and markets medical devices. The Company offers patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems.
SmarTrend is tracking the current trend status for Mindray Medical International and will alert subscribers who have MR in their portfolio or watchlist when shares have changed trend direction.
Keywords: analyst upgrades/downgrades mindray medical international